Cargando…

Anakinra for patients with COVID-19

Detalles Bibliográficos
Autores principales:	Martin-Silva, Nicolas, Boysson, Hubert de, Aouba, Achille
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316462/ https://www.ncbi.nlm.nih.gov/pubmed/32835235 http://dx.doi.org/10.1016/S2665-9913(20)30178-8

Ejemplares similares

An Updated Review of Cardiovascular Events in Giant Cell Arteritis
por: de Boysson, Hubert, et al.
Publicado: (2022)

Chronic intestinal pseudo-obstruction with dilated biliary tract as a spectrum of stiff person syndrome in a nondiabetic patient
por: Nguyen, Alexandre, et al.
Publicado: (2019)

Impact of Glucocorticoid Cumulative Doses in a Real-Life Cohort of Patients Affected by Giant Cell Arteritis
por: Castan, Paul, et al.
Publicado: (2022)

Whole‐Country and Regional Incidences of Giant Cell Arteritis in French Continental and Overseas Territories: A 7‐Year Nationwide Database Analysis
por: Guittet, Lydia, et al.
Publicado: (2022)

Evolution of the Therapeutic Management of Giant Cell Arteritis: Analysis of Real-Life Practices over Two Timeframes (2014–2017 and 2018–2020)
por: de Boysson, Hubert, et al.
Publicado: (2023)

Anakinra for patients with COVID-19
por: Maoujoud, Omar, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Valette, Xavier, et al.
Publicado: (2020)

[(18)F]FDG PET-MR characterization of aortitis in the IL1rn(−/−) mouse model of giant-cell arteritis
por: Deshayes, Samuel, et al.
Publicado: (2023)

Impact of Giant Cell Arteritis and Its Treatment on the Patient's Quality of Life: A Single-Center Self-Assessment Study
por: de Boysson, Hubert, et al.
Publicado: (2021)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A French Multicenter Study of 17 Cases and Literature Review
por: de Boysson, Hubert, et al.
Publicado: (2016)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease pattern
por: de Boysson, Hubert, et al.
Publicado: (2016)

Anakinra for severe forms of COVID-19
por: Laine, Marc, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Naim Akhtar
Publicado: (2020)

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Current evidence on the use of anakinra in COVID-19
por: Khani, Elnaz, et al.
Publicado: (2022)

Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: A retrospective single-center study
por: Vautier, Mathieu, et al.
Publicado: (2016)

Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19 †
por: García-García, José A, et al.
Publicado: (2021)

Anakinra: a silver lining in COVID-19?
por: Gupta, Rahul
Publicado: (2020)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial
por: Audemard-Verger, Alexandra, et al.
Publicado: (2022)

Efficacy of Anakinra for Various Types of Crystal-Induced Arthritis in Complex Hospitalized Patients: A Case Series and Review of the Literature
por: Aouba, A., et al.
Publicado: (2015)

Cytokine storm and use of anakinra in a patient with COVID-19
por: Nemchand, Priyanka, et al.
Publicado: (2020)

Anakinra in COVID-19: important considerations for clinical trials
por: King, Andrew, et al.
Publicado: (2020)

Anakinra in COVID-19: A step closer to the cure
por: Barkas, Fotios, et al.
Publicado: (2022)

Sustained Response and Rationale of Programmed Cell Death-1-Targeting for Progressive Multifocal Leukoencephalopathy
por: Audemard-Verger, Alexandra, et al.
Publicado: (2019)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

EMA assessing safety of anakinra in adults with COVID-19
Publicado: (2021)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Jaundice in a patient treated with Anakinra in a context of Covid-19
por: Tarhini, H., et al.
Publicado: (2021)

Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
por: Dimopoulos, George, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19: a cohort study
por: Huet, Thomas, et al.
Publicado: (2020)

Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19()
por: Muñoz-Jiménez, Alejandro, et al.
Publicado: (2021)

Evaluation of the effects of anakinra treatment on clinic and laboratory results in patients with COVID-19
por: Siyer, Ozge, et al.
Publicado: (2023)

Use of anakinra in severe COVID-19: A case report
por: Filocamo, Giovanni, et al.
Publicado: (2020)

(18)F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: A multicenter cohort of 130 patients
por: de Boysson, Hubert, et al.
Publicado: (2016)

Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis
por: de Boysson, Hubert, et al.
Publicado: (2021)

Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
por: Kooistra, Emma J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kv2ckdpvjtljo34cnrar8fjkn5